Agilent Technologies beats estimates, raises guidance on strong demand

Investing.com -- Agilent Technologies Inc (NYSE: A) reported third-quarter results that exceeded analyst expectations and raised its full-year guidance, driven by improving end markets and strong product demand. Shares rose 3% in after-hours trading Wednesday.

The analytical and clinical laboratory technology company posted adjusted earnings per share of $1.62 for the third quarter ended July 31, 2026, beating the analyst consensus of $1.49 by $0.13. Revenue reached $1.88 billion, up 8.1% YoY and above the $1.84 billion estimate. The adjusted EPS included a $0.06 benefit from tariff refunds. Agilent raised its fiscal 2026 adjusted EPS guidance to a range of $6.18 to $6.21, with a midpoint of $6.195 that exceeds the analyst consensus of $6.06. The company also increased its full-year revenue outlook to $7.49 billion to $7.51 billion, representing growth of 7.8% to 8.1%, up 65 basis points at the midpoint from prior guidance.

For the fourth quarter, Agilent expects revenue of $1.98 billion to $2.0 billion and adjusted EPS of $1.71 to $1.74. The revenue guidance midpoint of $1.99 billion represents growth of approximately 6.9% YoY on a reported basis.

"Agilent's exceptional third-quarter performance reflects the sustained momentum created by our strategy, our execution discipline, and the compounding impact of the Ignite Operating System," said CEO Padraig McDonnell. "We are seeing improving end markets, stronger demand in key regions, and excellent customer response to our innovative product launches."

The company's adjusted operating margin expanded 320 basis points YoY to 28.3%, which included a 110 basis point benefit from tariff refunds. All three business segments posted revenue growth, with the Life Sciences and Diagnostics Markets Group leading at 11% reported growth to $746 million.

You May Also Be Interested In

• Agilent Technologies (A) Tops Q3 EPS by 13c, Beats on Revenue; Offers FY EPS Guidance
• Implantica to host Capital Markets Day in Stockholm on September 9
• Citi sees an opportunity in Oracle after ’one of the most extreme’ stock drawdowns